With Ozempic and Wegovy generating $20B+ annually, semaglutide technology transfer is one of the most significant opportunities in pharmaceutical manufacturing.
Diabetes
Albumin-bound paclitaxel requires specialized manufacturing. Insights on scaling nanoparticle formulations for commercial production.
Oncology
Humira's patent cliff creates major opportunities for biosimilar manufacturers in emerging markets worldwide.
Immunology
How to structure regulatory documentation for simultaneous submission to FDA, EMA, Health Canada, TGA, and PMDA.
Regulatory
Technology transfer as a pathway to pharmaceutical self-sufficiency in Eastern Europe, Middle East, Africa, and Southeast Asia.
IndustryQuality & Compliance
GMP compliant · Health Canada, FDA, EMA, TGA, PMDA submissions · Vancouver, BC